Local bullous reaction as a cutaneous reaction after mRNA‐boosted vaccination in a post‐COVID patient

Coronavirus disease 2019 (COVID‐19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). The spectrum of symptomatic infection ranges from mild to critical with multiple severe complications. Many vaccines have been developed to prevent COVID‐19 disease, including an mRNA vacci...

Descripción completa

Detalles Bibliográficos
Autores principales: Kultawanich, Kwanhatai, Sampattavanich, Nattaporn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9675867/
https://www.ncbi.nlm.nih.gov/pubmed/36415713
http://dx.doi.org/10.1002/ccr3.6610
_version_ 1784833467282882560
author Kultawanich, Kwanhatai
Sampattavanich, Nattaporn
author_facet Kultawanich, Kwanhatai
Sampattavanich, Nattaporn
author_sort Kultawanich, Kwanhatai
collection PubMed
description Coronavirus disease 2019 (COVID‐19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). The spectrum of symptomatic infection ranges from mild to critical with multiple severe complications. Many vaccines have been developed to prevent COVID‐19 disease, including an mRNA vaccine. Different adverse effects were reported as delayed large local reactions, swelling, erythema, urticarial, and morbilliform rashes. Among these, bullous reactions from the vaccine are considered rare. Here, we described a local bullous reaction after an mRNA booster vaccination in a post‐COVID patient.
format Online
Article
Text
id pubmed-9675867
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-96758672022-11-21 Local bullous reaction as a cutaneous reaction after mRNA‐boosted vaccination in a post‐COVID patient Kultawanich, Kwanhatai Sampattavanich, Nattaporn Clin Case Rep Case Report Coronavirus disease 2019 (COVID‐19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). The spectrum of symptomatic infection ranges from mild to critical with multiple severe complications. Many vaccines have been developed to prevent COVID‐19 disease, including an mRNA vaccine. Different adverse effects were reported as delayed large local reactions, swelling, erythema, urticarial, and morbilliform rashes. Among these, bullous reactions from the vaccine are considered rare. Here, we described a local bullous reaction after an mRNA booster vaccination in a post‐COVID patient. John Wiley and Sons Inc. 2022-11-19 /pmc/articles/PMC9675867/ /pubmed/36415713 http://dx.doi.org/10.1002/ccr3.6610 Text en © 2022 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Case Report
Kultawanich, Kwanhatai
Sampattavanich, Nattaporn
Local bullous reaction as a cutaneous reaction after mRNA‐boosted vaccination in a post‐COVID patient
title Local bullous reaction as a cutaneous reaction after mRNA‐boosted vaccination in a post‐COVID patient
title_full Local bullous reaction as a cutaneous reaction after mRNA‐boosted vaccination in a post‐COVID patient
title_fullStr Local bullous reaction as a cutaneous reaction after mRNA‐boosted vaccination in a post‐COVID patient
title_full_unstemmed Local bullous reaction as a cutaneous reaction after mRNA‐boosted vaccination in a post‐COVID patient
title_short Local bullous reaction as a cutaneous reaction after mRNA‐boosted vaccination in a post‐COVID patient
title_sort local bullous reaction as a cutaneous reaction after mrna‐boosted vaccination in a post‐covid patient
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9675867/
https://www.ncbi.nlm.nih.gov/pubmed/36415713
http://dx.doi.org/10.1002/ccr3.6610
work_keys_str_mv AT kultawanichkwanhatai localbullousreactionasacutaneousreactionaftermrnaboostedvaccinationinapostcovidpatient
AT sampattavanichnattaporn localbullousreactionasacutaneousreactionaftermrnaboostedvaccinationinapostcovidpatient

Ejemplares similares